0001209191-22-009249.txt : 20220214 0001209191-22-009249.hdr.sgml : 20220214 20220214162242 ACCESSION NUMBER: 0001209191-22-009249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220210 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tatsis Ourania CENTRAL INDEX KEY: 0001789815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22632559 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-10 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001789815 Tatsis Ourania C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Reg. & Quality Off. Common Stock 2022-02-10 4 F 0 1230 237.74 D 58027 D Common Stock 2022-02-11 4 S 0 100 233.92 D 57927 D Common Stock 2022-02-11 4 S 0 78 234.93 D 57849 D Common Stock 2022-02-11 4 S 0 70 235.87 D 57779 D Common Stock 2022-02-11 4 S 0 42 236.85 D 57737 D Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.26 to $234.24). Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $234.93 (range $234.28 to $235.25). Open market sales reported on this line occurred at a weighted average price of $235.87 (range $235.41 to $236.08). Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.84 to $236.87). /s/ Sabrina Yohai, Attorney-in-Fact 2022-02-14